正海生物
(300653)
| 流通市值：36.58亿 | | | 总市值：36.58亿 |
| 流通股本：1.80亿 | | | 总股本：1.80亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 67,486,496.32 | 49,300,436.41 | 66,588,190.74 | 116,837,501.64 |
| 交易性金融资产 | 544,945,809.95 | 536,826,468.71 | 594,367,157.89 | 505,429,367.62 |
| 应收票据及应收账款 | 57,821,391.78 | 56,744,406.77 | 52,834,184.4 | 48,826,312.59 |
| 其中：应收票据 | - | - | 331,161.6 | 331,161.6 |
| 应收账款 | 57,821,391.78 | 56,744,406.77 | 52,503,022.8 | 48,495,150.99 |
| 应收款项融资 | 736,310.4 | 1,310,891.2 | 1,361,635.8 | 1,944,481.9 |
| 预付款项 | 9,287,442.42 | 7,845,110.89 | 4,415,997.63 | 3,441,253.12 |
| 其他应收款合计 | 2,233,538.95 | 1,936,321.44 | 1,269,434.17 | 636,852.06 |
| 存货 | 29,664,271.05 | 29,665,575.98 | 28,257,139.6 | 35,183,154.31 |
| 其他流动资产 | - | - | - | 401,570.02 |
| 流动资产合计 | 712,175,260.87 | 683,629,211.4 | 749,093,740.23 | 712,700,493.26 |
| 非流动资产: | | | | |
| 投资性房地产 | - | - | 66,322.85 | 66,322.85 |
| 固定资产 | 215,655,656.68 | 220,224,421.7 | 224,843,942.51 | 228,744,485.59 |
| 在建工程 | 1,777,758.47 | 1,257,377.65 | 1,226,512.28 | 1,344,330.41 |
| 无形资产 | 30,558,318.27 | 31,211,319.01 | 31,871,459.89 | 32,531,600.77 |
| 长期待摊费用 | - | - | - | 15,880.52 |
| 递延所得税资产 | 1,883,583.19 | 1,862,039.72 | 2,242,178.32 | 2,327,839.65 |
| 其他非流动资产 | 2,801,565 | 2,442,850.5 | 2,356,664.39 | 2,382,668.94 |
| 非流动资产合计 | 252,676,881.61 | 256,998,008.58 | 262,607,080.24 | 267,413,128.73 |
| 资产总计 | 964,852,142.48 | 940,627,219.98 | 1,011,700,820.47 | 980,113,621.99 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 12,074,965.69 | 13,806,938.76 | 16,770,442.7 | 21,818,777.78 |
| 其中：应付票据 | - | 709,997 | 4,187,004.86 | 5,158,073.65 |
| 应付账款 | 12,074,965.69 | 13,096,941.76 | 12,583,437.84 | 16,660,704.13 |
| 合同负债 | 8,076,066.9 | 8,248,837.42 | 13,399,499.91 | 13,938,496.36 |
| 应付职工薪酬 | 17,020,474.41 | 14,939,551.13 | 10,505,942.77 | 10,460,971.86 |
| 应交税费 | 6,485,681.76 | 5,006,240.65 | 10,960,242.04 | 3,138,154.98 |
| 其他应付款合计 | 36,299,079.01 | 34,463,926.35 | 33,965,588.98 | 31,325,220.85 |
| 其他流动负债 | 143,902.7 | 166,362.86 | 462,315.2 | 107,647.87 |
| 流动负债合计 | 80,100,170.47 | 76,631,857.17 | 86,064,031.6 | 80,789,269.7 |
| 非流动负债: | | | | |
| 递延收益 | 4,686,565.76 | 4,564,320.92 | 4,719,276.08 | 4,874,231.24 |
| 递延所得税负债 | 5,593,455.67 | 5,875,554.49 | 5,506,657.86 | 5,665,989.31 |
| 非流动负债合计 | 10,280,021.43 | 10,439,875.41 | 10,225,933.94 | 10,540,220.55 |
| 负债合计 | 90,380,191.9 | 87,071,732.58 | 96,289,965.54 | 91,329,490.25 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 180,000,000 | 180,000,000 | 180,000,000 | 180,000,000 |
| 资本公积 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 | 169,418,284.73 |
| 减:库存股 | 49,920,352.99 | 49,920,352.99 | 49,920,352.99 | 49,920,352.99 |
| 盈余公积 | 99,202,234.55 | 99,202,234.55 | 99,202,234.55 | 99,202,234.55 |
| 未分配利润 | 475,771,784.29 | 454,855,321.11 | 516,710,688.64 | 490,083,965.45 |
| 归属于母公司股东权益合计 | 874,471,950.58 | 853,555,487.4 | 915,410,854.93 | 888,784,131.74 |
| 股东权益合计 | 874,471,950.58 | 853,555,487.4 | 915,410,854.93 | 888,784,131.74 |
| 负债和股东权益合计 | 964,852,142.48 | 940,627,219.98 | 1,011,700,820.47 | 980,113,621.99 |
| 公告日期 | 2025-10-25 | 2025-08-05 | 2025-04-22 | 2025-04-15 |
| 审计意见(境内) | | | | 标准无保留意见 |